EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Targeting NLRP3/caspase-1/GSDMD to treat inner ear injury from labyrinthine hemorrhage

Qiong Wu, Mingwei Xu, Yuan Yao, Tianyu Gong, Qin Zhang, Yulian Jin, Jun Yang, Qing Zhang

Molecular Therapy · 2025

DOI: 10.1016/j.ymthe.2025.06.034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2025. Verfasst von Qiong Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China; Ear In…. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Caspase 1, Phosphate-Binding Proteins, Ear, Inner. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, School of Medicine, Shanghai Jiao Tong University, Key Research and Development Projects of Shaanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sudden sensorineural hearing loss (SSNHL) is a prevalent condition in otolaryngology with poorly understood mechanisms. Inner ear labyrinthine hemorrhage (IELH) is a potentially significant cause. Our study focused on the NLR family pyrin domain containing 3 (NLRP3) inflammasome activation following IELH and the protective role of the NLRP3 inhibitor CY-09. In mice with IELH, significant increases in hearing thresholds and vestibular dysfunction were observed compared with control groups. The activation of the NLRP3 inflammasome and other pro-inflammatory factors were markedly elevated, leading to potential damage in cochlear and vestibular hair cells via the Gasdermin D (GSDMD)-mediated pyroptosis pathway. Treatment with CY-09 significantly ameliorated hearing loss and vestibular dysfunction via inhibition of the NLRP3 inflammasome and associated cell pyroptosis. These results highlight the critical roles of the NLRP3 inflammasome and pyroptosis in IELH-induced SSNHL and suggest the NLRP3/caspase-1/GSDMD pathway as a therapeutic target for managing this condition. This study offers a new theoretical basis for the potential clinical management of SSNHL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinCaspase 1Phosphate-Binding ProteinsEar, InnerHemorrhageIntracellular Signaling Peptides and ProteinsLabyrinth DiseasesAnimalsMiceInflammasomesPyroptosisDisease Models, AnimalHumansHearing Loss, SensorineuralGasdermins

Stichwörter der Autor:innen

CY-09 inhibitorNLRP3 inflammasomeacute inner ear injuryinflammasome inhibitorinner ear hemorrhapglabyrinthine hemorrhagepyroptosissudden sensorineural hearing losstreatment

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinCaspase 1Phosphate-Binding ProteinsInflammasomesGsdmd protein, mouseNlrp3 protein, mouseIntracellular Signaling Peptides and ProteinsCasp1 protein, mouseGasdermins

Autor:innen und Institutionen

  • Department of Otolaryngology, Head and Neck Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China; Ear Institute, Shanghai Jiaotong University School of Medicine, Shanghai 200…
  • Ear Institute, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China; Shanghai Key Laboratory of Translational Medicine in Ear and Nose Diseases, Shanghai 200092, China; Diagnosis and Treatment Center…

Förderung

  • National Key Research and Development Program of China
  • School of Medicine, Shanghai Jiao Tong University
  • Key Research and Development Projects of Shaanxi Province
  • National Natural Science Foundation of China

Zitieren

APA

Wu, Q., Xu, M., Yao, Y., Gong, T., Zhang, Q., Jin, Y., Yang, J., & Zhang, Q. (2025). Targeting NLRP3/caspase-1/GSDMD to treat inner ear injury from labyrinthine hemorrhage. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2025.06.034

Vancouver

Wu Q, Xu M, Yao Y, Gong T, Zhang Q, Jin Y, et al. Targeting NLRP3/caspase-1/GSDMD to treat inner ear injury from labyrinthine hemorrhage. Molecular Therapy. 2025. doi:10.1016/j.ymthe.2025.06.034

BibTeX
@article{Wu2025,
  author = {Wu, Qiong and Xu, Mingwei and Yao, Yuan and Gong, Tianyu and Zhang, Qin and Jin, Yulian and Yang, Jun and Zhang, Qing},
  title = {Targeting NLRP3/caspase-1/GSDMD to treat inner ear injury from labyrinthine hemorrhage},
  journal = {Molecular Therapy},
  year = {2025},
  doi = {10.1016/j.ymthe.2025.06.034}
}
Kostenlos starten →